<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1511" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1511/" /><meta name="ncbi_pagename" content="Charcot-Marie-Tooth Neuropathy Type 2A - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Charcot-Marie-Tooth Neuropathy Type 2A - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Charcot-Marie-Tooth Neuropathy Type 2A" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2013/08/01" /><meta name="citation_author" content="Stephan Züchner" /><meta name="citation_pmid" content="20301684" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1511/" /><meta name="citation_keywords" content="CMT2A" /><meta name="citation_keywords" content="Hereditary and Motor Sensory Neuropathy IIA" /><meta name="citation_keywords" content="HMSN2A" /><meta name="citation_keywords" content="HMSNIIA" /><meta name="citation_keywords" content="Charcot-Marie-Tooth Neuropathy Type 2A2" /><meta name="citation_keywords" content="CMT 2A2" /><meta name="citation_keywords" content="Mitofusin-2" /><meta name="citation_keywords" content="MFN2" /><meta name="citation_keywords" content="CMT2A2" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Charcot-Marie-Tooth Neuropathy Type 2A" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Stephan Züchner" /><meta name="DC.Date" content="2013/08/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1511/" /><meta name="description" content="Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A) is a classic axonal peripheral sensorimotor neuropathy characterized by earlier and more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (&gt;42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Most affected individuals develop symptoms in the first or second decade. It has recently been suggested that CMT2A represents more than 90% of the severe dominant CMT2 cases. However, milder late-onset cases and unusual presentations have also been described." /><meta name="og:title" content="Charcot-Marie-Tooth Neuropathy Type 2A" /><meta name="og:type" content="book" /><meta name="og:description" content="Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A) is a classic axonal peripheral sensorimotor neuropathy characterized by earlier and more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (&gt;42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Most affected individuals develop symptoms in the first or second decade. It has recently been suggested that CMT2A represents more than 90% of the severe dominant CMT2 cases. However, milder late-onset cases and unusual presentations have also been described." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1511/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cmt2a/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1511/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BB663E04058D100000000083F02E7.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1511_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1511_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt2e/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1511_"><span class="title" itemprop="name">Charcot-Marie-Tooth Neuropathy Type 2A</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: CMT2A, Hereditary and Motor Sensory Neuropathy IIA, HMSN2A, HMSNIIA</div><p class="contrib-group"><span itemprop="author">Stephan Z&#x000fc;chner</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1511_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1511_ai__"><div class="contrib half_rhythm"><span itemprop="author">Stephan Z&#x000fc;chner</span>, MD, PhD<div class="affiliation small">Department of Human Genetics<br />University of Miami Miller School of Medicine<br />Miami, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imaim.dem@renhcuzs" class="oemail">ude.imaim.dem@renhcuzs</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 18, 2005</span>; Last Update: <span itemprop="dateModified">August 1, 2013</span>.</p><p><em>Estimated reading time: 13 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cmt2a.Summary" itemprop="description"><h2 id="_cmt2a_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A) is a classic axonal peripheral sensorimotor neuropathy characterized by earlier and more severe involvement of the lower extremities than the upper extremities, distal upper-extremity involvement as the neuropathy progresses, more prominent motor deficits than sensory deficits, and normal (&#x0003e;42 m/s) or only slightly decreased nerve conduction velocities (NCVs). Postural tremor is common. Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop symptoms in the first or second decade. It has recently been suggested that CMT2A represents more than 90% of the severe dominant CMT2 cases. However, milder late-onset cases and unusual presentations have also been described.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis is established by clinical and molecular genetic findings. <i>MFN2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CMT2A.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Treatment by a team including a neurologist, physiatrist, orthopedic surgeon, and physical and occupational therapists; special shoes and/or ankle/foot orthoses to correct foot drop and aid walking; surgery as needed for severe <i>pes cavus</i>; forearm crutches, canes, wheelchairs as needed for mobility; exercise as tolerated; acetaminophen or nonsteroidal anti-inflammatory agents for musculoskeletal pain; treatment of neuropathic pain with tricyclic antidepressants or drugs like carbamazepine or gabapentin.</p><p><i>Surveillance</i>: Annual neurologic evaluation of gait, strength, and visual acuity.</p><p><i>Agents/circumstances to avoid</i>: Obesity (which makes ambulation more difficult); medications (e.g., vincristine, isoniazid, nitrofurantoin) known to cause nerve damage; alcohol and malnutrition (which can cause or exacerbate neuropathy).</p><p><i>Other</i>: Career/employment counseling.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CMT2A is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with CMT2A have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. The proportion of cases caused by <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variants is unknown. Each child of an individual with CMT2A has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal diagnosis for pregnancies at increased risk for CMT2A is possible if the pathogenic variant has been identified in an affected family member.</p></div></div><div id="cmt2a.Diagnosis"><h2 id="_cmt2a_Diagnosis_">Diagnosis</h2><div id="cmt2a.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A) is a classic axonal peripheral sensorimotor neuropathy diagnosed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>MFN2</i>.</p><p>No specific findings distinguish CMT2A from other types of CMT2. However, in young and severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with CMT2, <i>MFN2</i> pathogenic variants are the most frequent cause of disease. Typical findings include the following:</p><ul><li class="half_rhythm"><div>Involvement of the lower extremities earlier and more severely than the upper extremities</div></li><li class="half_rhythm"><div>Involvement of the distal upper extremities as the neuropathy progresses</div></li><li class="half_rhythm"><div>Motor deficits more prominent than sensory deficits</div></li><li class="half_rhythm"><div>Normal (&#x0003e;42 m/s) or only slightly decreased nerve conduction velocities (NCVs) [<a class="bk_pop" href="#cmt2a.REF.saito.1997.1630">Saito et al 1997</a>, <a class="bk_pop" href="#cmt2a.REF.z_chner.2004.449">Z&#x000fc;chner et al 2004</a>]</div></li><li class="half_rhythm"><div>Onset before age ten years (however, a wide range of age of onset has been reported)</div></li></ul></div><div id="cmt2a.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b>
<i>MFN2</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause CMT2A.</p><div id="cmt2a.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Charcot-Marie-Tooth Neuropathy Type 2A</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1511/table/cmt2a.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2a.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Proportion of CMT2A Attributed to Pathogenic Variants in Gene</th><th id="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variants Detected&#x000a0;<sup>2</sup></th></tr></thead><tbody><tr><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>MFN2</i></td><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Nearly 100%</td><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup> / scanning for pathogenic variants&#x000a0;<sup>4</sup></td><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants</td></tr><tr><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis of select exons&#x000a0;<sup>3,</sup>&#x000a0;<sup>5</sup></td><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence variants in select exons</td></tr><tr><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_cmt2a.T.molecular_genetic_testing_used_i_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cmt2a.TF.1.1"><p class="no_margin">See <a href="/books/NBK1511/#cmt2a.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cmt2a.TF.1.2"><p class="no_margin">See <a href="#cmt2a.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>3. </dt><dd><div id="cmt2a.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cmt2a.TF.1.4"><p class="no_margin">Sequence analysis and scanning of the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for pathogenic variants can have similar variant detection frequencies; however, variant detection rates for scanning may vary considerably between laboratories depending on the specific protocol used.</p></div></dd><dt>5. </dt><dd><div id="cmt2a.TF.1.5"><p class="no_margin">Select exons may vary by laboratory.</p></div></dd><dt>6. </dt><dd><div id="cmt2a.TF.1.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not readily detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="cmt2a.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#cmt2a.REF.polke.2011.168">Polke et al [2011]</a></p></div></dd></dl></div></div></div></div><div id="cmt2a.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>,</b> identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MFN2</i> is necessary.</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin"><i>MFN2</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> should be performed first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found by sequence analysis, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> of <i>MFN2</i> should be considered.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MFN2</i> is identified by <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analaysis, iterative <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> strategies have been suggested for CMT based on extensive genetic testing results [<a class="bk_pop" href="#cmt2a.REF.saporta.2011.22">Saporta et al 2011</a>].</p></dd></dl><p><b>Predictive testing</b> for at-risk asymptomatic adult family members requires prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p><p><b>Prenatal diagnosis</b>
<b>and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> (PGD)</b> for at-risk pregnancies require prior identification of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family.</p></div></div><div id="cmt2a.Clinical_Characteristics"><h2 id="_cmt2a_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cmt2a.Clinical_Description"><h3>Clinical Description</h3><p>The age at onset and disease progression of Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A) vary within and among families; onset ranges from age one year to the sixth decade. Most individuals develop symptoms in the first or second decade. The initial finding is often foot drop or foot weakness. <i>Pes cavus</i> foot deformity may occur.</p><p>Motor signs (weakness and atrophy) predominate, but mild sensory loss in the feet is common. Tendon reflexes are usually absent, but occasionally intact.</p><p>Some individuals with <i>MFN2</i> pathogenic variants are asymptomatic and have only mild findings on examination; however, those could eventually convert to late-onset cases [<a class="bk_pop" href="#cmt2a.REF.lawson.2005.197">Lawson et al 2005</a>].</p><p>Postural tremor is common [<a class="bk_pop" href="#cmt2a.REF.muglia.2001.100">Muglia et al 2001</a>, <a class="bk_pop" href="#cmt2a.REF.bissartadmouri.2004.1522">Bissar-Tadmouri et al 2004</a>].</p><p>Affected individuals with early onset (age &#x0003c;10 years) tend to have more severe disability than those with later onset [<a class="bk_pop" href="#cmt2a.REF.chung.2006.2103">Chung et al 2006</a>]. Those with early onset may show optic atrophy, hoarse voice, and proximal weakness. Subacute onset of optic atrophy with subsequent slow recovery in 60% of individuals with early onset was reported by <a class="bk_pop" href="#cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner et al [2006]</a>, and confirmed by <a class="bk_pop" href="#cmt2a.REF.chung.2006.2103">Chung et al [2006]</a> and <a class="bk_pop" href="#cmt2a.REF.verhoeven.2006.2093">Verhoeven et al [2006]</a>.</p><p>The disease course is progressive. Although some individuals become dependent on crutches or a wheelchair, most do not [<a class="bk_pop" href="#cmt2a.REF.muglia.2001.100">Muglia et al 2001</a>]. Life span is usually not reduced.</p><p><b>Neuroimaging.</b> Periventricular and subcortical white matter lesions on brain MRI have been reported in a few individuals [<a class="bk_pop" href="#cmt2a.REF.chung.2006.2103">Chung et al 2006</a>, <a class="bk_pop" href="#cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner et al 2006</a>].</p><p><b>Neuropathology.</b> Neuropathologic findings include loss of myelinated nerve fibers (especially large fibers), mitochondrial abnormalities and, rarely, onion bulb formation [<a class="bk_pop" href="#cmt2a.REF.saito.1997.1630">Saito et al 1997</a>, <a class="bk_pop" href="#cmt2a.REF.muglia.2001.100">Muglia et al 2001</a>, <a class="bk_pop" href="#cmt2a.REF.verhoeven.2006.2093">Verhoeven et al 2006</a>].</p></div><div id="cmt2a.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No apparent <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation has been reported except in one family in which truncation of the protein led to a more severe phenotype with visual impairment [<a class="bk_pop" href="#cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner et al 2006</a>]. Some rare families with recessive <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> changes in <i>MFN2</i> have been reported which all showed early onset of disease [<a class="bk_pop" href="#cmt2a.REF.polke.2011.168">Polke et al 2011</a>]. Individuals with optic atrophy (HMSN VI) tend to show a more severe phenotype; several of these individuals were found to have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner et al 2006</a>].</p></div><div id="cmt2a.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is considered to be complete. Some individuals with <i>MFN2</i> pathogenic variants are asymptomatic and have only mild findings on examination; in these cases, however, the disease may prove to be late onset [<a class="bk_pop" href="#cmt2a.REF.lawson.2005.197">Lawson et al 2005</a>].</p></div><div id="cmt2a.Anticipation"><h3>Anticipation</h3><p>While some authors have considered the possibility of <a class="def" href="/books/n/gene/glossary/def-item/anticipation/">anticipation</a> in CMT2A, it has not been reported [<a class="bk_pop" href="#cmt2a.REF.muglia.2001.100">Muglia et al 2001</a>].</p></div><div id="cmt2a.Nomenclature"><h3>Nomenclature</h3><p>CMT2A is an axonal neuropathy (indicated by the number 2) and was the first CMT2 form to be linked to a chromosomal <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> (indicated by the letter A).</p><p>In addition to the pure CMT2A <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, CMT2 with optic atrophy, also known as hereditary motor and sensory neuropathy VI (HMSN VI), has been reported in a number of individuals [<a class="bk_pop" href="#cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner et al 2006</a>] (see <a href="#cmt2a.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>).</p><p><a class="bk_pop" href="#cmt2a.REF.chung.2006.2103">Chung et al [2006]</a> suggested the division into "early-onset severe CMT2A <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>" and "late-onset mild CMT2A phenotype" owing to <i>MFN2</i> pathogenic variants. All reported persons with HMSN VI with <i>MFN2</i> pathogenic variants had early-onset severe CMT2.</p><p>All reported persons with HMSN VI with <i>MFN2</i> pathogenic variants had early-onset severe CMT2.</p></div><div id="cmt2a.Prevalence"><h3>Prevalence</h3><p>The proportion of CMT caused by pathogenic variants in <i>MFN2</i> varies by study:</p><ul><li class="half_rhythm"><div><a class="bk_pop" href="#cmt2a.REF.z_chner.2004.449">Z&#x000fc;chner et al [2004]</a> reported seven <i>MFN2</i> pathogenic variants in 36 families with CMT2, indicating that 19.5% of CMT2 could be caused by mutation of this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cmt2a.REF.chung.2006.2103">Chung et al [2006]</a> reported that 24% of 62 families with CMT2 in South Korea had pathogenic variants in <i>MFN2</i>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cmt2a.REF.verhoeven.2006.2093">Verhoeven et al [2006]</a> reported that 33% of families with CMT2 in a European/USA study had pathogenic variants in <i>MFN2</i>.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cmt2a.REF.engelfried.2006.53">Engelfried et al [2006]</a> reported that 8% (6/73) of persons with CMT2, including <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family), had <i>MFN2</i> pathogenic variants.</div></li><li class="half_rhythm"><div><a class="bk_pop" href="#cmt2a.REF.feely.2011.1690">Feely et al [2011]</a> reported that CMT2A accounted for 91% of severely impaired individuals with CMT2 but only 11% of mildly or moderately impaired people.</div></li><li class="half_rhythm"><div>The majority of reported cases of optic atrophy associated with the CMT2A <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (previously called HMSN VI) resulted from <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>MFN2</i> pathogenic variants.</div></li></ul></div></div><div id="cmt2a.Genetically_Related_Allelic_Disord"><h2 id="_cmt2a_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b><i>MFN2</i>.</b> The association of CMT2A and optic atrophy caused by pathogenic variants in <i>MFN2</i> is also known as hereditary motor and sensory neuropathy VI (HMSN VI).</p><p>CMT2 with pyramidal signs, also known as HMSN VII, has been associated with <i>MFN2</i> pathogenic variants [<a class="bk_pop" href="#cmt2a.REF.zhu.2005.496">Zhu et al 2005</a>]. HMSN VII is characterized by an axonal CMT <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with mild pyramidal signs, including extensor plantar responses, mild increase in tone, and preserved or increased reflexes, but no spastic gait [<a class="bk_pop" href="#cmt2a.REF.vucic.2003.696">Vucic et al 2003</a>]. In addition, pathogenic variants in <i>MFN2</i> have been associated with early-onset stroke [<a class="bk_pop" href="#cmt2a.REF.chung.2008.2010">Chung et al 2008</a>].</p></div><div id="cmt2a.Differential_Diagnosis"><h2 id="_cmt2a_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a href="/books/n/gene/cmt/">Charcot-Marie-Tooth Hereditary Neuropathy Overview</a>.</p><p>All CMT forms in which axonal phenotypes have been reported, including CMT1A (caused by pathogenic variants in <i>PMP22</i>), CMT1B (caused by pathogenic variants in <i>MPZ</i>), and <a href="/books/n/gene/cmtx/">CMT1X</a> (caused by pathogenic variants in <i>GJB1</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the protein connexin 32), need to be considered in the differential diagnosis of CMT2A.</p><p><i>MFN2</i> pathogenic variants may prove to be the most common cause of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> CMT2. As many as one third of all individuals with CMT2 with a positive family history have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MFN2</i> [<a class="bk_pop" href="#cmt2a.REF.verhoeven.2006.2093">Verhoeven et al 2006</a>]. Thus, testing of <i>MFN2</i> is probably the first genetic test to consider in families with an axonal neuropathy demonstrating male-to-male transmission.</p></div><div id="cmt2a.Management"><h2 id="_cmt2a_Management_">Management</h2><div id="cmt2a.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Charcot-Marie-Tooth hereditary neuropathy type 2A (CMT2A), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>EMG with NCV</div></li><li class="half_rhythm"><div>Visual evoked potentials</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="cmt2a.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is often managed by a multidisciplinary team that includes a neurologist, physiatrist, orthopedic surgeon, and physical and occupational therapists [<a class="bk_pop" href="#cmt2a.REF.carter.1995.s140">Carter et al 1995</a>]. Treatment is symptomatic and may include the following:</p><ul><li class="half_rhythm"><div>Daily heel cord stretching exercises to prevent Achilles tendon shortening</div></li><li class="half_rhythm"><div>Special shoes, including those with good ankle support</div></li><li class="half_rhythm"><div>Ankle/foot orthoses to correct foot drop and aid walking [<a class="bk_pop" href="#cmt2a.REF.carter.1995.s140">Carter et al 1995</a>]</div></li><li class="half_rhythm"><div>Orthopedic surgery to correct severe <i>pes cavus</i> deformity [<a class="bk_pop" href="#cmt2a.REF.holmes.1993.476">Holmes &#x00026; Hansen 1993</a>, <a class="bk_pop" href="#cmt2a.REF.guyton.2000.317">Guyton &#x00026; Mann 2000</a>]</div></li><li class="half_rhythm"><div>Forearm crutches or canes for gait stability</div></li><li class="half_rhythm"><div>Wheelchairs for mobility because of gait instability</div></li><li class="half_rhythm"><div>Exercise within the individual's capability</div></li><li class="half_rhythm"><div>Treatment of musculoskeletal pain with acetaminophen or nonsteroidal anti-inflammatory agents [<a class="bk_pop" href="#cmt2a.REF.carter.1998.1560">Carter et al 1998</a>]</div></li><li class="half_rhythm"><div>Treatment of neuropathic pain with tricyclic antidepressants or drugs such as carbamazepine or gabapentin</div></li><li class="half_rhythm"><div>Career and employment counseling because of persistent weakness of hands and/or feet</div></li></ul></div><div id="cmt2a.Surveillance"><h3>Surveillance</h3><p>Annual neurologic evaluation of gait, strength, and visual acuity is appropriate.</p></div><div id="cmt2a.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Obesity is to be avoided because it makes walking more difficult.</p><p>Medications that are toxic or potentially toxic to persons with CMT comprise a spectrum of risk ranging from definite high risk to negligible risk. See the Charcot-Marie-Tooth Association <a href="https://www.cmtausa.org/living-with-cmt/managing-cmt/medications/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">website</a> (pdf) for an up-to-date list.</p></div><div id="cmt2a.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#cmt2a.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cmt2a.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p><a class="bk_pop" href="#cmt2a.REF.dyck.1982.239">Dyck et al [1982]</a>, <a class="bk_pop" href="#cmt2a.REF.donaghy.2000.799">Donaghy et al [2000]</a>, and <a class="bk_pop" href="#cmt2a.REF.ginsberg.2004.193">Ginsberg et al [2004]</a> have described a few individuals with CMT1 and sudden deterioration in whom treatment with steroids (prednisone) or intravenous immunoglobulin has produced variable levels of improvement. No similar report on CMT2A exists.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="cmt2a.Genetic_Counseling"><h2 id="_cmt2a_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cmt2a.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Charcot-Marie-Tooth neuropathy type 2A (CMT2A) is inherited an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="cmt2a.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with CMT2A have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with CMT2A may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The proportion of cases caused by <i>de novo</i> pathogenic variants is unknown.</div></li><li class="half_rhythm"><div>It is appropriate to evaluate the parents of an individual with CMT2A in order to determine which, if either, is symptomatic, both to assure appropriate medical management for that individual and for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> of the family.</div></li></ul><p>Note: Although most individuals diagnosed with CMT2A have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents.</div></li><li class="half_rhythm"><div>If a parent has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low. No instances of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> have been reported, although it remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with CMT2A has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members are at risk.</p></div><div id="cmt2a.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has clinical evidence of the disorder or the pathogenic variant, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cmt2a.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cmt2a.Resources"><h2 id="_cmt2a_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Association CMT France</b></div><div>France</div><div><b>Phone:</b> 820 077 540; 2 47 27 96 41 </div><div><a href="http://www.cmt-france.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmt-france.org</a></div></li><li class="half_rhythm"><div><b>Charcot-Marie-Tooth Association (CMTA)</b></div><div>PO Box 105</div><div>Glenolden PA 19036</div><div><b>Phone:</b> 800-606-2682 (toll-free); 610-499-9264</div><div><b>Fax:</b> 610-499-9267</div><div><b>Email:</b> info@cmtausa.org</div><div><a href="http://www.cmtausa.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cmtausa.org</a></div></li><li class="half_rhythm"><div><b>European Charcot-Marie-Tooth Consortium</b></div><div>Department of Molecular Genetics</div><div>University of Antwerp</div><div>Antwerp Antwerpen B-2610</div><div>Belgium</div><div><b>Fax:</b> 03 2651002</div><div><b>Email:</b> gisele.smeyers@ua.ac.be</div></li><li class="half_rhythm"><div><b>Hereditary Neuropathy Foundation, Inc.</b></div><div>432 Park Avenue South</div><div>4th Floor</div><div>New York NY 10016</div><div><b>Phone:</b> 855-435-7268 (toll-free); 212-722-8396</div><div><b>Fax:</b> 917-591-2758</div><div><b>Email:</b> info@hnf-cure.org</div><div><a href="http://www.hnf-cure.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hnf-cure.org</a></div></li><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Charcot%20Marie%20Tooth%20disease&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot Marie Tooth disease</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=charcotmarietoothdisease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth disease</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22241/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth syndrome</a></div></li><li class="half_rhythm"><div><b>TREAT-NMD</b></div><div>Institute of Genetic Medicine</div><div>University of Newcastle upon Tyne </div><div>International Centre for Life </div><div> Newcastle upon Tyne NE1 3BZ</div><div>United Kingdom</div><div><b>Phone:</b> 44 (0)191 241 8617</div><div><b>Fax:</b> 44 (0)191 241 8770</div><div><b>Email:</b> info@treat-nmd.eu</div><div><a href="http://www.treat-nmd.eu/cmt/overview/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Charcot-Marie-Tooth Disease</a></div></li><li class="half_rhythm"><div><b>Association Francaise contre les Myopathies (AFM)</b></div><div>1 Rue de l'International</div><div>BP59</div><div>Evry cedex 91002</div><div>France</div><div><b>Phone:</b> +33 01 69 47 28 28</div><div><b>Email:</b> dmc@afm.genethon.fr</div><div><a href="http://www.afm-telethon.fr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.afm-telethon.fr </a></div></li><li class="half_rhythm"><div><b>European Neuromuscular Centre (ENMC)</b></div><div>Lt Gen van Heutszlaan 6</div><div>3743 JN Baarn</div><div>Netherlands</div><div><b>Phone:</b> 31 35 5480481</div><div><b>Fax:</b> 31 35 5480499</div><div><b>Email:</b> enmc@enmc.org</div><div><a href="http://www.enmc.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.enmc.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy Association - USA (MDA)</b></div><div>222 South Riverside Plaza</div><div>Suite 1500</div><div>Chicago IL 60606</div><div><b>Phone:</b> 800-572-1717</div><div><b>Email:</b> mda@mdausa.org</div><div><a href="http://www.mda.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mda.org</a></div></li><li class="half_rhythm"><div><b>Muscular Dystrophy UK</b></div><div>61A Great Suffolk Street</div><div>London SE1 0BU </div><div>United Kingdom</div><div><b>Phone:</b> 0800 652 6352 (toll-free); 020 7803 4800</div><div><b>Email:</b> info@musculardystrophyuk.org</div><div><a href="http://www.musculardystrophyuk.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.musculardystrophyuk.org</a></div></li><li class="half_rhythm"><div><b>RDCRN Patient Contact Registry: Inherited Neuropathies Consortium</b></div><div><a href="https://www.rarediseasesnetwork.org/cms/inc" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Patient Contact Registry</a></div></li></ul></div><div id="cmt2a.Molecular_Genetics"><h2 id="_cmt2a_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cmt2a.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Charcot-Marie-Tooth Neuropathy Type 2A: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1511/table/cmt2a.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2a.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cmt2a.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Locus Name</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cmt2a.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cmt2a.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">CMT2A2</td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9927" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>MFN2</i></a></td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9927" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.22</a></td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95140" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mitofusin-2</a></td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.molgen.ua.ac.be/CMTMutations/Mutations/Contexts.cfm?ID=32" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">IPN Mutations, MFN2</a><br /><a href="https://databases.lovd.nl/shared/genes/MFN2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MFN2 homepage - Leiden Muscular Dystrophy pages</a></td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=MFN2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MFN2</a></td><td headers="hd_b_cmt2a.molgen.TA_1_1_1_7" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=MFN2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MFN2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cmt2a.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cmt2a.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Charcot-Marie-Tooth Neuropathy Type 2A (<a href="/omim/608507,609260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1511/table/cmt2a.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cmt2a.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608507" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608507</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MITOFUSIN 2; MFN2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609260" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609260</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2A2A; CMT2A2A</td></tr></tbody></table></div></div><div id="cmt2a.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>The disease mechanism leading to CMT is unknown.</p><div id="cmt2a.MFN2"><h4><i>MFN2</i></h4><p><b>Gene structure.</b>
<i>MFN2</i> has 17 exons and 4,546 nucleotides in the <a class="def" href="/books/n/gene/glossary/def-item/open-reading-frame/">open reading frame</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1511/#cmt2a.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, more than 50 pathogenic variants have been reported. The majority were <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; frameshift and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have also been reported [<a class="bk_pop" href="#cmt2a.REF.z_chner.2004.449">Z&#x000fc;chner et al 2004</a>, <a class="bk_pop" href="#cmt2a.REF.verhoeven.2006.2093">Verhoeven et al 2006</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>MFN2</i> encodes a large GTPase of 757 amino acids that is situated at the outer mitochondrial membrane [<a class="bk_pop" href="#cmt2a.REF.rojo.2002.1663">Rojo et al 2002</a>]. It has been shown that <i>MFN2</i> accounts for the fusion/fission balance of mitochondria [<a class="bk_pop" href="#cmt2a.REF.santel.2001.867">Santel &#x00026; Fuller 2001</a>]. Recently, evidence for direct involvement of <i>MFN2</i> in fusion of mitochondria has been reported [<a class="bk_pop" href="#cmt2a.REF.koshiba.2004.858">Koshiba et al 2004</a>]. The gene is ubiquitously expressed [<a class="bk_pop" href="#cmt2a.REF.santel.2001.867">Santel &#x00026; Fuller 2001</a>].</p><p>Larger insertions and duplications are not known to be involved in CMT2A, but could represent rare mutational mechanisms.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Most pathogenic variants are in the GTPase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>, but other parts of the protein are also <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. The GTPase domain may be crucial for the development of peripheral neuropathy. Pathogenic variants may affect both mitochondrial fusion and energy metabolism [<a class="bk_pop" href="#cmt2a.REF.pich.2005.1405">Pich et al 2005</a>]. <a class="bk_pop" href="#cmt2a.REF.baloh.2007.422">Baloh et al [2007]</a> reported altered axonal mitochondrial transport resulting from CMT2A-related <i>MFN2</i> pathogenic variants.</p></div></div></div><div id="cmt2a.References"><h2 id="_cmt2a_References_">References</h2><div id="cmt2a.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.baloh.2007.422">Baloh RH, Schmidt RE, Pestronk A, Milbrandt J. Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations. <span><span class="ref-journal">J Neurosci. </span>2007;<span class="ref-vol">27</span>:422–30.</span> [<a href="/pmc/articles/PMC6672077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6672077</span></a>] [<a href="/pubmed/17215403" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17215403</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.bissartadmouri.2004.1522">Bissar-Tadmouri N, Nelis E, Z&#x000fc;chner S, Parman Y, Deymeer F, Serdaroglu P, De Jonghe P, Van Gerwen V, Timmerman V, Schr&#x000f6;der JM, Battaloglu E. Absence of KIF1B mutation in a large Turkish CMT2A family suggests involvement of a second gene. <span><span class="ref-journal">Neurology. </span>2004;<span class="ref-vol">62</span>:1522–5.</span> [<a href="/pubmed/15136675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15136675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.carter.1995.s140">Carter GT, Abresch RT, Fowler WM Jr, Johnson ER, Kilmer DD, McDonald CM. Profiles of neuromuscular diseases. Hereditary motor and sensory neuropathy, types I and II. <span><span class="ref-journal">Am J Phys Med Rehabil. </span>1995;<span class="ref-vol">74</span>:S140–9.</span> [<a href="/pubmed/7576421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7576421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.carter.1998.1560">Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD. Neuropathic pain in Charcot-Marie-Tooth disease. <span><span class="ref-journal">Arch Phys Med Rehabil. </span>1998;<span class="ref-vol">79</span>:1560–4.</span> [<a href="/pubmed/9862301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9862301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.chung.2008.2010">Chung KW, Cho SY, Hwang SJ, Kim KH, Yoo JH, Kwon O, Kim SM, Sunwoo IN, Z&#x000fc;chner S, Choi BO. Early-onset stroke associated with a mutation in mitofusin 2. <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>:2010–1.</span> [<a href="/pubmed/18490623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18490623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.chung.2006.2103">Chung KW, Kim SB, Park KD, Choi KG, Lee JH, Eun HW, Suh JS, Hwang JH, Kim WK, Seo BC, Kim SH, Son IH, Kim SM, Sunwoo IN, Choi BO. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2103–18.</span> [<a href="/pubmed/16835246" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835246</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.donaghy.2000.799">Donaghy M, Sisodiya SM, Kennett R, McDonald B, Haites N, Bell C. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2000;<span class="ref-vol">69</span>:799–805.</span> [<a href="/pmc/articles/PMC1737181/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1737181</span></a>] [<a href="/pubmed/11080236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11080236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.dyck.1982.239">Dyck PJ, Swanson CJ, Low PA, Bartleson JD, Lambert EH. Prednisone-responsive hereditary motor and sensory neuropathy. <span><span class="ref-journal">Mayo Clin Proc. </span>1982;<span class="ref-vol">57</span>:239–46.</span> [<a href="/pubmed/7070119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7070119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.engelfried.2006.53">Engelfried K, Vorgerd M, Hagedorn M, Haas G, Gilles J, Epplen JT, Meins M. Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). <span><span class="ref-journal">BMC Med Genet. </span>2006;<span class="ref-vol">7</span>:53.</span> [<a href="/pmc/articles/PMC1524942/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1524942</span></a>] [<a href="/pubmed/16762064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16762064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.feely.2011.1690">Feely SM, Laura M, Siskind CE, Sottile S, Davis M, Gibbons VS, Reilly MM, Shy ME. MFN2 mutations cause severe phenotypes in most patients with CMT2A. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:1690–6.</span> [<a href="/pmc/articles/PMC3100135/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3100135</span></a>] [<a href="/pubmed/21508331" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21508331</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.ginsberg.2004.193">Ginsberg L, Malik O, Kenton AR, Sharp D, Muddle JR, Davis MB, Winer JB, Orrell RW, King RH. Coexistent hereditary and inflammatory neuropathy. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:193–202.</span> [<a href="/pubmed/14607795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14607795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.guyton.2000.317">Guyton GP, Mann RA. The pathogenesis and surgical management of foot deformity in Charcot-Marie-Tooth disease. <span><span class="ref-journal">Foot Ankle Clin. </span>2000;<span class="ref-vol">5</span>:317–26.</span> [<a href="/pubmed/11232233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11232233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.holmes.1993.476">Holmes JR, Hansen ST Jr. Foot and ankle manifestations of Charcot-Marie-Tooth disease. <span><span class="ref-journal">Foot Ankle. </span>1993;<span class="ref-vol">14</span>:476–86.</span> [<a href="/pubmed/8253442" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8253442</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.koshiba.2004.858">Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM, Chan DC. Structural basis of mitochondrial tethering by mitofusin complexes. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">305</span>:858–62.</span> [<a href="/pubmed/15297672" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15297672</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.lawson.2005.197">Lawson VH, Graham BV, Flanigan KM. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">65</span>:197–204.</span> [<a href="/pubmed/16043786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16043786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.muglia.2001.100">Muglia M, Zappia M, Timmerman V, Valentino P, Gabriele AL, Conforti FL, De Jonghe P, Ragno M, Mazzei R, Sabatelli M, Nicoletti G, Patitucci AM, Oliveri RL, Bono F, Gambardella A, Quattrone A. Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">56</span>:100–3.</span> [<a href="/pubmed/11148244" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11148244</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.pich.2005.1405">Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palac&#x000ed;n M, Zorzano A. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. <span><span class="ref-journal">Hum Mol Genet. </span>2005;<span class="ref-vol">14</span>:1405–15.</span> [<a href="/pubmed/15829499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15829499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.polke.2011.168">Polke JM, Laur&#x000e1; M, Pareyson D, Taroni F, Milani M, Bergamin G, Gibbons VS, Houlden H, Chamley SC, Blake J, Devile C, Sandford R, Sweeney MG, Davis MB, Reilly MM. Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">77</span>:168–73.</span> [<a href="/pmc/articles/PMC3140074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3140074</span></a>] [<a href="/pubmed/21715711" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21715711</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.rojo.2002.1663">Rojo M, Legros F, Chateau D, Lomb&#x000e8;s A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. <span><span class="ref-journal">J Cell Sci. </span>2002;<span class="ref-vol">115</span>:1663–74.</span> [<a href="/pubmed/11950885" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11950885</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.saito.1997.1630">Saito M, Hayashi Y, Suzuki T, Tanaka H, Hozumi I, Tsuji S. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. <span><span class="ref-journal">Neurology. </span>1997;<span class="ref-vol">49</span>:1630–5.</span> [<a href="/pubmed/9409358" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9409358</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.santel.2001.867">Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. <span><span class="ref-journal">J Cell Sci. </span>2001;<span class="ref-vol">114</span>:867–74.</span> [<a href="/pubmed/11181170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11181170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.saporta.2011.22">Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME. Charcot-Marie-Tooth disease subtypes and genetic testing strategies. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">69</span>:22–33.</span> [<a href="/pmc/articles/PMC3058597/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3058597</span></a>] [<a href="/pubmed/21280073" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21280073</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.verhoeven.2006.2093">Verhoeven K, Claeys KG, Z&#x000fc;chner S, Schr&#x000f6;der JM, Weis J, Ceuterick C, Jordanova A, Nelis E, De Vriendt E, Van Hul M, Seeman P, Mazanec R, Saifi GM, Szigeti K, Mancias P, Butler IJ, Kochanski A, Ryniewicz B, De Bleecker J, Van den Bergh P, Verellen C, Van Coster R, Goemans N, Auer-Grumbach M, Robberecht W, Milic Rasic V, Nevo Y, Tournev I, Guergueltcheva V, Roelens F, Vieregge P, Vinci P, Moreno MT, Christen HJ, Shy ME, Lupski JR, Vance JM, De Jonghe P, Timmerman V. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:2093–102.</span> [<a href="/pubmed/16714318" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16714318</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.vucic.2003.696">Vucic S, Kennerson M, Zhu D, Miedema E, Kok C, Nicholson GA. CMT with pyramidal features. Charcot-Marie-Tooth. <span><span class="ref-journal">Neurology. </span>2003;<span class="ref-vol">60</span>:696–9.</span> [<a href="/pubmed/12601114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12601114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.zhu.2005.496">Zhu D, Kennerson ML, Walizada G, Z&#x000fc;chner S, Vance JM, Nicholson GA. Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">65</span>:496–7.</span> [<a href="/pubmed/16087932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16087932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.z_chner.2006.276">Z&#x000fc;chner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, Cherninkova S, Hamilton SR, Van Stavern G, Krajewski KM, Stajich J, Tournev I, Verhoeven K, Langerhorst CT, de Visser M, Baas F, Bird T, Timmerman V, Shy M, Vance JM. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:276–81.</span> [<a href="/pubmed/16437557" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16437557</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cmt2a.REF.z_chner.2004.449">Z&#x000fc;chner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu E, Polyakov AV, Timmerman V, Schr&#x000f6;der JM, Vance JM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:449–51.</span> [<a href="/pubmed/15064763" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15064763</span></a>]</div></li></ul></div></div><div id="cmt2a.Chapter_Notes"><h2 id="_cmt2a_Chapter_Notes_">Chapter Notes</h2><div id="cmt2a.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 August 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 June 2010 (cd) Revision: edits to Agents/Circumstances to Avoid</div></li><li class="half_rhythm"><div>12 September 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>23 January 2006 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for <i>MFN2</i> mutations clinically available</div></li><li class="half_rhythm"><div>18 February 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>13 September 2004 (sz) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1511</span><span class="label">PMID: <a href="/pubmed/20301684" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301684</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt2e/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1511&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1511/?report=reader">PubReader</a></li><li><a href="/books/NBK1511/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1511" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1511" style="display:none" title="Cite this Page"><div class="bk_tt">Züchner S. Charcot-Marie-Tooth Neuropathy Type 2A. 2005 Feb 18 [Updated 2013 Aug 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1511/pdf/Bookshelf_NBK1511.pdf">PDF version of this page</a> (183K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cmt2a.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cmt2a.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cmt2a.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cmt2a.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cmt2a.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cmt2a.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cmt2a.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cmt2a.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cmt2a.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cmt2a.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cmt2a.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=23095[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KIF1B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9927[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">MFN2</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1492832" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1492832" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1492832" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1492832" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301462" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301641" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 4<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20614582" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">DNM2</i>-Related Intermediate Charcot-Marie-Tooth Neuropathy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Züchner S, Tao F. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301384" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301366" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Charcot-Marie-Tooth Neuropathy Type 2E/1F<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">De Jonghe P, Jordanova AK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301684" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301684" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04194239a66ee2ba4fe362">Charcot-Marie-Tooth Neuropathy Type 2A - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Charcot-Marie-Tooth Neuropathy Type 2A - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:21:54-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BB663E04058D100000000083F02E7&amp;ncbi_session=CE8BB663E0419411_2111SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1511%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1511&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1511/&amp;ncbi_pagename=Charcot-Marie-Tooth Neuropathy Type 2A - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BB663E0419411_2111SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>